Eligard Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

ELIGARD 7.5 mg: One prefilled syringe with powder for solution for injection contains 7.5 mg leuprorelin acetate, equivalent to 6.96 mg leuprorelin.
ELIGARD 22.5 mg: One prefilled syringe with powder for solution for injection contains 22.5 mg leuprorelin acetate, equivalent to 20.87 mg leuprorelin.
ELIGARD 45 mg: One prefilled syringe with powder for solution for injection contains 45 mg leuprorelin acetate, equivalent to 41.7 mg leuprorelin.
Excipients/Inactive Ingredients: ELIGARD 7.5 mg: Solvent (syringe A): Poly (DL-lactic-co-glycolic-acid) (50:50); N-Methyl-pyrrolidone.
ELIGARD 22.5 mg: Solvent (syringe A): Poly (DL-lactic-co-glycolic-acid) (75:25); N-Methylpyrrolidone.
ELIGARD 45 mg: Solvent (syringe A): Poly (DL-lactic-co-glycolic-acid) (85:15); N-Methylpyrrolidone.
Powder (syringe B): None.

leuprorelin

Manufacturer:

Tolmar

Distributor:

DCH Auriga